PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31991183-0	2020	CD13-specific Ligand Facilitates Xanthatin Nanomedicine Targeting Dendritic Cells for Therapy of Refractory Allergic Rhinitis.	xanthatin	33-42	alanyl (membrane) aminopeptidase	Mus musculus	0-4	
31991183-8	2020	These indicated CD13-specific NGR could facilitate XT selectively targeting DCs for efficiently ameliorating refractory rhinitis, and NGR-XT-PM should be a potential anti-AR drug.	xanthatin	51-53	alanyl (membrane) aminopeptidase	Mus musculus	16-20